Collegium Pharma (COLL) Stock Price, Quote & News

Company Profile

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-dete...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 713 3699

Website: www.collegiumpharma.com

Address:

100 Technology Center Drive, Suite 300, Stoughton, United States

jewell69 Sep. 8 at 7:15 PM

$COLL 2nd buy today throwing good money after bad. Buy 50 Limit $37.58 Day $37.58 $37.90 $37.91 $37.94

0 · Reply

jewell69 Sep. 8 at 2:56 PM

$COLL got opium ? truth be told; pain medicine Settlement date: 09/09/2025 Action: Bought Quantity: 50 Symbol: COLL Unit price: $38.09 Principal amount $1,904.5*

0 · Reply

jewell69 Sep. 6 at 7:39 PM

set it, and forget it ! for Monday, trying to buy 50 $COLL 38.09 rationale: -.6% lower than friday 9/5/25 close

0 · Reply

jewell69 Sep. 6 at 7:34 PM

$COLL modest+ earnings beat 8/7/25; up about a half a ton since then, but -3.04% last 10 trading days; including -2.32% on Friday 9/5 traded out of it for smallish profits Date Jun-06-2025 Shares -500.000 Price $29.85 Amount $14,923.75 friday 9/5 close 38.32 obviously, you would be paying up since 8/7 earnings beat

0 · Reply

Doozio Sep. 6 at 4:03 AM

$COLL it was always 🐒🍌🧠⏰♾️ wen yo wud get tight with the da huckleberries below da $$$$$. Whuts that 🐑 short interest????

0 · Reply

Estimize Aug. 25 at 1:03 PM

Wall St is expecting 1.88 EPS for $COLL Q3 [Reporting 11/06 BMO] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co

0 · Reply

MergeMarkets Aug. 23 at 10:01 AM

$COLL Collegium Pharmaceutical Inc is facing opioid litigation concerns and generic competition risks

0 · Reply

stockpicker63 Aug. 15 at 6:04 PM

Nice profits on the free tips van Swingstocktraders. $AUPH now +34%, $PLUG now +16%, $ELAN +5%, $COLL +5.5%, $KOD +18%.

1 · Reply

net0trader Aug. 13 at 6:56 PM

$ANIP $CELC $COLL I am out of all 3 names ..

0 · Reply

net0trader Aug. 13 at 1:56 AM

$ANIP $CELC $COLL these really exceeded my expectations... Quite some momentum

0 · Reply

Collegium Pharmaceutical, Inc. (COLL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 28, 2025, 8:00 AM EDT - 15 days ago

Collegium to Participate in Upcoming Investor Conferences

Aug 25, 2025, 8:00 AM EDT - 18 days ago

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

Aug 7, 2025, 2:00 PM EDT - 5 weeks ago

Collegium Pharmaceutical, Inc. (COLL) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:30 AM EDT - 5 weeks ago

Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook

Jul 24, 2025, 8:00 AM EDT - 7 weeks ago

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 7, 2025, 8:00 AM EDT - 2 months ago

Collegium Announces $150 Million Share Repurchase Program

Jun 30, 2025, 2:53 PM EDT - 2 months ago

Collegium Pharmaceutical: Stock Deserves A "Buy" Call On Undervaluation Of ADHD Drug

May 12, 2025, 8:05 AM EDT - 4 months ago

Collegium Announces $25 Million Accelerated Share Repurchase Program

May 9, 2025, 2:04 AM EDT - 4 months ago

Collegium Pharmaceutical, Inc. (COLL) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:01 PM EDT - 4 months ago

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Apr 24, 2025, 8:00 AM EDT - 5 months ago

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 1, 2025, 8:00 AM EDT - 5 months ago

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Mar 27, 2025, 8:00 AM EDT - 6 months ago

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting

Mar 17, 2025, 7:00 AM EDT - 6 months ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Mar 10, 2025, 6:57 PM EDT - 6 months ago

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Mar 9, 2025, 4:07 AM EDT - 6 months ago

Collegium Pharmaceutical's Shareholders Might Be In For A Pain-Free 2025

Feb 27, 2025, 9:03 PM EST - 7 months ago

Collegium Pharmaceutical, Inc. (COLL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:01 PM EST - 7 months ago

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Feb 13, 2025, 8:00 AM EST - 7 months ago

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Jan 8, 2025, 8:00 AM EST - 8 months ago

Collegium Provides 2025 Financial Guidance and Business Update

Nov 26, 2024, 8:00 AM EST - 10 months ago

Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion

Nov 14, 2024, 4:30 PM EST - 10 months ago

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

Nov 8, 2024, 12:30 AM EST - 11 months ago

Collegium Pharmaceutical, Inc. (COLL) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:02 PM EST - 11 months ago

Collegium Reports Record Third Quarter 2024 Financial Results

Aug 30, 2024, 8:00 AM EDT - 1 year ago

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 8, 2024, 9:30 PM EDT - 1 year ago

Collegium Pharmaceutical, Inc. (COLL) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Collegium Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 6:00 AM EDT - 1 year ago

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

May 29, 2024, 8:00 AM EDT - 1 year ago

Collegium to Participate in Jefferies Global Healthcare Conference

May 13, 2024, 8:00 AM EDT - 1 year ago

Collegium Announces $35 Million Accelerated Share Repurchase Program

May 9, 2024, 7:32 PM EDT - 1 year ago

Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:02 PM EDT - 1 year ago

Collegium Reports First Quarter 2024 Financial Results

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

Mar 12, 2024, 5:00 AM EDT - 1 year ago

Top 10 Small-Cap Stocks (SA Quant)

ANIP APOG BASE BLBD GCT PLMR RAMP

Feb 22, 2024, 9:52 PM EST - 1 year ago

Collegium Pharmaceutical's (COLL) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 4:09 PM EST - 1 year ago

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

Feb 8, 2024, 8:00 AM EST - 1 year ago

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Nov 27, 2023, 8:00 AM EST - 1 year ago

Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent

Nov 7, 2023, 10:15 PM EST - 2 years ago

Collegium Pharmaceutical, Inc. (COLL) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:01 PM EST - 2 years ago

Collegium Reports Third Quarter 2023 Financial Results

Oct 24, 2023, 2:59 PM EDT - 2 years ago

Collegium Pharmaceutical: Delivering On Promises

Oct 24, 2023, 8:00 AM EDT - 2 years ago

Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023

Aug 28, 2023, 8:00 AM EDT - 2 years ago

Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023

Aug 24, 2023, 8:00 AM EDT - 2 years ago

Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026

Aug 12, 2023, 5:25 AM EDT - 2 years ago

Collegium Pharmaceutical: Pipeline Continues As Share Buyback Initiates

Aug 11, 2023, 11:20 AM EDT - 2 years ago

With 30% Returns On Capital Deployed At 4.4x Earnings, Collegium Is A Buy

Aug 7, 2023, 7:30 AM EDT - 2 years ago

Collegium Announces $50 Million Accelerated Share Repurchase Program

Aug 4, 2023, 4:50 PM EDT - 2 years ago

Collegium Pharmaceutical, Inc. (COLL) Q2 2023 Earnings Call Transcript

jewell69 Sep. 8 at 7:15 PM

$COLL 2nd buy today throwing good money after bad. Buy 50 Limit $37.58 Day $37.58 $37.90 $37.91 $37.94

0 · Reply

jewell69 Sep. 8 at 2:56 PM

$COLL got opium ? truth be told; pain medicine Settlement date: 09/09/2025 Action: Bought Quantity: 50 Symbol: COLL Unit price: $38.09 Principal amount $1,904.5*

0 · Reply

jewell69 Sep. 6 at 7:39 PM

set it, and forget it ! for Monday, trying to buy 50 $COLL 38.09 rationale: -.6% lower than friday 9/5/25 close

0 · Reply

jewell69 Sep. 6 at 7:34 PM

0 · Reply

Doozio Sep. 6 at 4:03 AM

$COLL it was always 🐒🍌🧠⏰♾️ wen yo wud get tight with the da huckleberries below da $$$$$. Whuts that 🐑 short interest????

0 · Reply

Estimize Aug. 25 at 1:03 PM

Wall St is expecting 1.88 EPS for $COLL Q3 [Reporting 11/06 BMO] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co

0 · Reply

MergeMarkets Aug. 23 at 10:01 AM

$COLL Collegium Pharmaceutical Inc is facing opioid litigation concerns and generic competition risks

0 · Reply

stockpicker63 Aug. 15 at 6:04 PM

Nice profits on the free tips van Swingstocktraders. $AUPH now +34%, $PLUG now +16%, $ELAN +5%, $COLL +5.5%, $KOD +18%.

1 · Reply

net0trader Aug. 13 at 6:56 PM

$ANIP $CELC $COLL I am out of all 3 names ..

0 · Reply

net0trader Aug. 13 at 1:56 AM

$ANIP $CELC $COLL these really exceeded my expectations... Quite some momentum

0 · Reply

stockpicker63 Aug. 11 at 1:57 PM

Stocks to watch now! $COLL and $ELAN

0 · Reply

JarvisFlow Aug. 11 at 11:00 AM

HC Wainwright & Co. updates rating for Collegium Pharmaceutical ( $COLL ) to Buy, target set at 44.

0 · Reply

net0trader Aug. 10 at 8:38 PM

Some of the XBI names I am watching this week $ANIP $CELC $COLL . Cc @RonIsWrong

1 · Reply

d_risk Aug. 7 at 2:28 PM

$COLL - Collegium Pharmaceutical Inc. Common Stock - 10Q - Updated Risk Factors COLL’s 10-Q Risk Factors section returns with expanded, detailed disclosures covering business, financial, commercialization, IP, third-party, legal, regulatory, market, and stock risks, adding a comprehensive risk summary without removing prior content. #Pharmaceuticals #MarketVolatility #IntellectualProperty #RegulatoryCompliance #RiskManagement 🟢 Added 🟠 Removed https://d-risk.ai/COLL/10-Q/2025-08-07

0 · Reply

tommynos Aug. 7 at 1:20 PM

$COLL 60$ =4.5x ebitda

0 · Reply

Stefan100 Aug. 7 at 12:02 PM

$COLL earnings and guidance looked good https://ir.collegiumpharma.com/news-releases/news-release-details/collegium-reports-second-quarter-2025-financial-results-raises

2 · Reply

Stefan100 Jul. 8 at 3:31 PM

$COLL my research below. Pretty timely as the company is launching another buyback program of $150MM or 15% of market cap https://seekingalpha.com/article/4765962-collegium-pharmaceuticals-shareholders-might-be-in-for-a-pain-free-2025

2 · Reply

Itinerant Jul. 7 at 3:27 PM

$COLL I am impressed with the company's share buyback. They are not wrong. The stock is meaningfully under valued and the analysts' target of $41 is appropriate. I do worry about the legal issues, but the discount rate at $41 is 19%, which is rather substantial anyway.

0 · Reply

ISHARETRADEALERTS Jul. 7 at 12:00 PM

$COLL - Collegium Announces $150 Million Share Repurchase Program

0 · Reply

Itinerant Jul. 6 at 7:54 PM

$COLL I did a cursory analysis of this company, and while it looks somewhat cheap, I suspect that the market is concerned about the lawsuits. I appreciate that the company is buying in the stock, but the lawsuits are a risky overhang. I guess that is holding the stock down. What do you think?

1 · Reply

jewell69 Jun. 6 at 4:34 PM

$COLL got opium ? (a spoof on tv ads, got milk) took profits, but all $IBB $XBI is (APPARENTLY) up today 6/6/25 tryin 2 sell $FRSH 15.72 now b a .63 x .64 12:31 pm EDT

0 · Reply

jewell69 Jun. 3 at 5:47 PM

$COLL TRYIN 2 ChASE/ BUY 29.27 LAST TIME WE TOOK PROFITS WAS B4 NICE EARNIN ON 5/8/25 STOCK IS UP SINCE 5/8, BUT 10 DAY gRAPh IS DOWN 2 EYE LAShES Symbol description COLLEGIUM PHARMACEUTICAL INC COM Type Cash Shares -222.000 Price $27.14 Amount $6,023.80 Fees $0.17 Settlement date Apr-29-2025

0 · Reply

Market Cap	1.19B
Revenue (ttm)	631.45M
Net Income (ttm)	69.19M
EPS (ttm)	N/A
PE Ratio	6.54
Forward PE	6.11
Profit Margin	10.96%
Debt to Equity Ratio	2.52

Volume	539,500
Avg Vol	384,680
Day's Range	N/A - N/A
Shares Out	31.50M
Stochastic %K	73%
Beta	0.63
Analysts	Strong Sell
Price Target	$44.60